TRIOCHEM PRODUCTS LIMITEDMANUFACTURERS OF ETHICAI, PHARMACEUTICAL PRODUCTSRegistered Office: 4th Floor, Sambava Chainbers, Sir. P. M. Road,Fort, Munbal, Maliarashtra, PIN: 400001. Telephone: 00 91 (22) 4082 8100

J.ddfro``+I-``E-`f:`E`ni-,p-,,,~

FaK: 00 91 (22) 4082 8181 E.mall: info@amohrav.comWebsite: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544

Ref No: TPI, PP 200336 2020; 27thJune 2020

To

BSE Irfuted

Corporate Relationship Department,

PhirozeJeejechhoyTowers,

Dalal Street` Fort, Mumbai: 400 001.

Security Code No. 512101 -ISIN No.: INE331E01013.

D€'ar`Si-i-/M`a'd`an,

Sub: Outcome of the Board - Pursuant to Regulation 30 and 33 of the SEBI fhisting Obliszations and

Disclosures Reauirements\ Regrllation` 2015

Pursuant to Notice of Board meeting dated 17th June, 2020 the Board meeting was held on today

Saturday, 27th June, 2020 at 2.00 pin. at 4th Floor, Sambava Chambers, Sir P. M. Road, Fort Mumbai:

400001 and has approved the following:

1. The Board discussed and approved the Armual Financial Statements together with accounting

policies, schedules, and explanatory notes, as reviewed by the Audit Committee, for the year ended

31st March 2020 in accordance with provision of the Companies Act, 2013.

2. 'Ihe Board approved the Audited Finandal Results for the quarter / year ended on flat March 2020, as

reviewed by the Audit Committee, in accordance with Regulation 33 of SEBI qisting Obligations and

Disclosure Requirements) Regulation, 2015.

3. The Board noted and took on records the Audit Report for the year ended Slat March 2020, as placed

before the Board being the Unqualified Report. The approval of the Board was accorded to submit a

declaration on auditors report with unmodified opinion pursuant to the SEBI Circular no. CIR/CFD/

CMDrs6#016 dated May 27, 2016 and Notification no. SEB|/IAD-NRO#016-17AVl dated May 25,

20'16.

4. The 48th Annual General Meeting of the Company has been fixed on Saturday, 26th September, 2020

at 3.00 P.M at the ReSstered Office Of the Company at Sainbava Chambers, 4th Floor, Sir P. M Road,

0 001 and accordingly Books Closure date of the Company has been fixed from 18th

to 26th September 2020 (Both days Inclusive)

Page 1 of 2

a

a

TRIOCHEM PRODUCTS LIMITEDMANUFACTURERS OF E'IHICAI, PHARMACEUTICAL PROI)UCTSRegistered Office: 4th Flcoi., Sambava Chambers, Sir. P. M. Road,Fort, Munbai, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 4082 8100Far: 00 91 (22) 4082 8181 E.flrail: info@amolurav.com

---I`+.-.l€¥,ap.,+,.`+

Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544

5. Board Meeting commenced at 2.00 p.in. and concluded at 2.45 p.in.

You are requested to take note of the sane.

Thankingyou,

Yours faithfully,

For TRIOCHEM PRODUCTS I,IMITED

RAun s. DEORA

DIRECTOR

DIN: 00312369

Place: Munbai

Page 2 Of 2

TRI®CHEM PRODUCTS LIMITEDMANUFACTURIiRS OF ETHCAI, PHARMACEUHCAL PRODUCTSRegistered Office: 4th Floor, Sambava Chambers, Sir. P. M. Road,Fort, Munbal, Mcharashtra, PIN: 400001. Telephone: 00 91 (22) 4082 8100

````9`TiM,`.,/

Fax: 00 91 ¢2) 4082 8181 Email: i±±SQ{€iiangp_hray._€_Q_i_HWebsite: ww.thochenDroducas.com Corporate Identity Number: L24249MH1972PLC015544

Ref No: TPI. PP 200535 2020; 27th jue 2020

To

BSE Limited

Coxporate Relationship Department,

Phiroze ]eejeebhoy Towers, Dalal Street,

Fort` Mumbai: 400 001.

Security Code No. 512101 -ISIN No.: INE331E01013.

DearSir/Madani,

r) Sue: Submission of Audited Financial Resi]|¢s for the ouarter and Year ended 31SL Mach 2020

r)

We refer to our letter dated 17th June 2020 on the captioned subject.

Pursuant to Regulation 30 and 33 of SEBI qisting Obligations and Disclosure Requirements) Regulations,

2015, In tlris subject, we wish to inform you that the Board of Director of the Company at its meeting held

today i.e. Saturday, 27th June 2020 have intei.-alia considered and approved the Audited Financial Results

of the Company for the quattertyear ended 31S[ March, 2020 duly reviewed by the Audit Committee.

The said froancial results, duly signed by the Director & CEO Of the company along with the statutory

auditor's report with unmodified opinion thereon are enclosed for your perusal and records. A

declaration on auditor's report with urmodified opinion pursuant to the SEBI Circular no. CIR/CFD/CMD/

56/2016 dated May 2, 2016 and notification no. SEBI/LAD-NRO/2016-17/001 dated May 25, 2016 is also

enclosed.

Also, informed that the audited financial results in prescribed format will be published in "Free Press

]ournal" and "Naushakti" newspaper, as required. Please take the same in you record.

Thankingyou,

Yours faithfully,

For TRIOCHEM PRODUCTS LIMITED

RAMU SITARAM DEORA g.ifAtRAyMsigEnoegAby RAMU

Dat:e: 2020.06.2715:43:31 lsT

RAMU S. DEORA

I)IRECTOR & CEO

DIN: 00312369

End.: as above

Itanu Doshi Associates LLPChartered Accountants

Mumt)al Address : 203, The Summit. Hanuman Road,

Western Express Highway. Vile Parie (E), Mumbai -400 057T : 022-2615 0100 ` 111 / 112 . F : 022 2615 0113

Piine Address : 123, Sohrab Hall. 21 Sassoon Road,

Opp. Jchangir Hospital, Puns -411001 . T : 020 4906 7177

E : info@kdg.coin . W : un/w.kdg.co.in

Independent Auditor's Report on the Quarterly and Year to Date Financial Results ofthe Company Pursuant to the Regulations 33 and 52 Of the SEBl {Listing Obligationsand Disclosure Requirements} Regulations, 2015, as amended

TO,

The Board Of Directors of Triochem Products LimitedOpinion

We have auclited the acccimpanying statement Of Financial Results Qf Triochem ProductsLimited (`'the company") for the quarter ended March 31, 2020 and the year to date statementfor the period from April 01, 2019 to March 31, 2020, attached herewith, being submitted bythe company pursuant to the reqiiirement Of Regulatic)n 33 of the SEBl (Listing Obligationsanc! Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations").

In our opinion ancl to the best Of our information and according to the explanations given to usthese Financial results:

(i) are presentecl in accordance with the requirements Of Regulation 33 Of the ListingRegulations in this regard; and

(ii) give a true and fair view in confomity with the recognition ancl measurement principleslaid down in the applicable accounting standards and other accounting principlesgenerally accepted in India of the net profit and other comprehensive income and otherfinancial information for the quarter ended March 31, 2020 as well as the year tct datestatement for the period from April 01, 2019 to March 31, 2020.

Basis for Opinion

We conducted our audit in accordance with the Standards on Auditing (SAs) specified undersection 143(10) Of the Companies Act, 2013 (the Act). Our responsibilities under thoseStandards are further describecl in the Auditor's Re§pc]n§ibilitie§ for the Audit Of the FinancialResults section of our report. We are independent of the Company in accordance with theCode of Ethics issued by the Institute Of Chartered Accountants Of India together with theethical requirements that are relevant to our audit of the Financial Results under the provisionsof the Companies Act, 2013 and the Rules thereunder, and we have fulfilled our other ethicalresponsibilities in accordance with these requirements and the Code of Ethics. We believethat the audit evidence we have obtained is sufficient ancl appropriate to provide a basis forourapinion.

Management's Responsibilities for the Financial Results

These quarterly financial results as well as the year to date financial results have been

prepared on the basis Of the interim financial statements. The Company's Board of Directorsare responsible for the preparation of these Financial F2esults that give a true and fair view ofthe net profit and other comprehensive income and other financial information in accordancewith the recognition and measurement principles laid down in Indian Accounting Standard

Kanu Doshi AssoE;iates LLP coniinua{ion slio.3t

prescribed under Section 133 of the Act read with relevant rules issiied thereunder ancl otheraccounting principles generally accepted in India and in compliance with Regulation 33 of theListing Regulaticms. This responsibility also includes maintenance Of adequate accountingrecords in accordance with the provisions Of the Act for safeguarding of the assets Of theCompany and for preventing and cletecting frauds ancl other irregularities; selectior` andapplication of appropriate accounting policies; making judgments and estimates that arereasonable ancl prudent; ancl design, implementation and maintenance Of adequate intemalfinaricial controls that were operating effectively for ensuring the accuraey and completenessof the accounting records, relevant to the preparation ancl presentation of the FinancialStatements that give a true and fair view and are free from in?terial misstatement, whetherdue to fraud or error.

In preparing the Financial F{esults, the Board Of Directors are responsible for assessing theCQmpany's ability to continue as a going concern, disclc)sing, as applicable, matters related to

going concern and using the going concern basis of accounting unless the Bciard of Directorseither intends to liquidate the Company or to cease operations, or has nc) realistic alternativebut to do so.

The Board Of Directors are also responsible for overseeing the Company's financial reporting

Process.

Ai]ditor's Responsibilities for the Audit of the Financial Results

Our objectives are to obtain reasonable assurance about whether the Financial Results as awhole are free from material misstatement, whether due to fraud or error, and to issue anauditors report that inclucles our opinion. Reasonable a§§urance is a high level of as§iirance,but is not a guarantee that an audit conducted in accordance with SAs will always detect amaterial misstatement when it exists. Misstatements can arise from fraud or error and areconsiderecl material if, incliviclually or in the aggregate, they could reasonably be expected toinfluence the economic decisions Of users taken on the basis of these Financial Results.

As part Of an audit in accordance with SAs, we exercise professional judgment and maintain

professional skepticism throughout the audit. We also:• Identify ancl assess the risks of material misstatement of the Financial Results, whcther

due to fraud or error, design and perform audit procedures responsive to those risks,and obtain audit evidence that is sufficient ancl appropriate to provide a basis for ouropinion. The risk of not detecting a material misstatement resulting from fraucl is higherthan for one resulting from error, as fraud may involve collusion, forgery, intentionalomissions, misrepresentations, or the override Of internal control.

• Obtain an understanding of internal control relevant to the auclit in order to design audit

procedures that are appropriate in the circumstances, but not for the purpose Ofexpressing an opinion on the effectiveness Of the company's internal control.

• Evaluate the appropriateness of accounting policies used and the reasonableness Ofaccounting estimates ancl related disclosures made by the Bctard of Directors.

• Conclilde on the appropriateness of the Bciard Of Directors' use Of the going concernbasis of accounting and, basec! on the audit evidence obtained, whether a materialuncertainty exists related to events or conditions that may cast significant doubt on theCompany's ability to continue as a going concern. If we conclude that a materialuncertainty exists, we are required to draw attention in our auditor.s report to the

3

Kanu Doshi Associates LLP Coiilinuation Shoot

related clisclosures in the financial statement or, if such disclosures are inaclequate, tomodify our opinion. Our conclusions are based on the audit evidence obtained up tothe date Of our auclitor's report. However, future events or conditions may cause theCompany to ceaseto continue as a going concern. `

Evaluate the overall presentation, structure and content Of the Financial Results,including the disclosures, and whether the Financial Results represent the unclerlyingtransactions and events in a manner that achieves fair presentation.

We communicate with those charged with governance regarding, among other matters, the

planned scope and timing Of the audit and significant audit findings, including any significantcleficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied withrelevant ethical requirements regarding independence, and to communicate with them allrelationships and other matters that may reasonably be thought to bear on our independence,and where applicable, related safeguards.

For Kanu Doshi Associates LLP

Chartered Acco u ntantsFirm Registration No: 104746WAV100096

;!#;NRIA \¥ir¥¥Kunal Vakharia

Partner

Membership No: 148916

UDIN: 20148916AAAAC83522

Place: Mumbai

Date: Jiine 27, 2020

TRI®CHHM pR®HBurcTs ELIMITEE)MANIlmcTURERs OF ETHlcAI, pHARMACEUTlcAI, pRODucTsRealstered Office: 4'h Floor, Sambava Chambers, Sir. P. M. Road,Fort, Mumhai, Malarashtra, PIN: 400001. Telephone: 00 91 (22) 4082 8100Fax: 00 91 (22) 4082 8181 E-mail: i±_1_fQ|@ia±ng)lil.av.cojE

``,..``cHEM,,,``,\..,.

Website: www.triochemoroducts.com Corporate Identity Number: L24249rml972PI,C015544

Ref No: TPL PP 200334 2020; 27thTune 2020

To

BSE Lied

Corporate Relationship Department,

Phiroze Tepjeebhey Towers, Dalal Street,

EQff±noumbat~_Security Code No. 512101 -ISIN No.: INE331E01015_

a Dearsir/Madam,

S±rfeiLpedaptlon oD An]iul Audited Finandal Results oursuant to Realat{on 33r3) (a) o.f the Seflndtles

and Exchanse Board of India (SEBn thistine Obligations and Disclosure Requirelnentry)` Remlation 2015

The Board of Directors of the Company at its meeting held on 27in June, 2020 has approved the Audited

Financial Results of the Company for the year ended 31St March, 2020 and we hereby declare that the

Stamtory Auditors Of the Company, M/s. Kanu Doshi Associates LIT., Chartered Accountants, ¢RN:

104746WIV100096)haveissuedanAuditReportwlthurmodificdopindonthereon.

This declaration is issued in compliance with the provisions of the Regulation 33@)(d) of the Securities

and Exchange Board of India (SEED qisting Obligations and Disclosure Requirements) Regulation, 2015

as amended by the Securities and ELchange Board of India (SEED qisting Obligatious and Disclosure

Requirements) (Amendment), Regulation 2016 vide notification no. SEBMAD-NRO/2016-17/001 dated

May 25, 2016 and Cil'oular no. Cm/CFD/CMD/56/2016 dated May 27, 2016,

TheDeclarationmaykindlybetakenonyourfecords.

For TRIOCHEM PRODUCTS LrmTED

RAMU SITARAM DEORA B,ifAtgAyMsbgEnoeRAby RAMU

Date: 2020.06.2715:44:15 lsT

RAMU §. DEORA

DIRECTOR & CEO

DIN: 0031Z369

i:iiiiii=.r

•.I.

TRIOcHliM pRODuc'rs LnllTED

MANUEACTURERs cur ETHlcAL pHARMACEUTlcAL pRODucTs

RE+ggisteredOffice:4thFloor,SambavaChamber§,Sir.P.M.RQad,FDrLMumbai,Maliarashtra,PIN:400001.

I.clc'_phitnc: 00 91 (22) `1082 810r) f`ri:i 00 `J I (!2) i082 8181 E.niall.. info(/+`amphra\'.com

Wcbeirel ```\rw.mochen`DroducLi.com Corpo"c ldc.nlit` \.umber: lJ 12i9\IH 1972PLC0155 I.i

C tri E ri,?

TRIOCEIEM PRODUCTS I,IMITED

Registered office: Sambava Chamhas, 4th Floor, Sir P. M, Road, Fort, Mumbai - 400 001web§ite: www.triochemproducts.com

GIN: L24249MH1972PLC015544

AuniTED FINANclAI, REsuurs FOR TEIE QUARER AND yEAR ENDED 3isT MARCH 2020

Qs. in lckhe) Except EpsSrNo Particulars Quter Ended Year Ended

51.03.2020 31-12-2019 31J)3-2019 3103.2020 31-03.2019

(Audited)qeferNoteNo.5) qumudited) (Audited)queferNoteNo.5) (Audited) (drdited)

12545678910 hcome1,147.66 541.16 339.97 2,003.18 1,235,47(a) Revenue from Operahons

a) Other income 33.38 12.93 1.53 46.63 5.52

Total income from operations 1,181.04 554.09 341.50 2,049.81 1,240.99

Expenses:544.16 424.70 458.38(260.24) 968.86 1,099.78(a) Cost Of materials consumed

a) Purchase of stock-in.trade 3=.77 4.78 37.55 55.60

(a) Changes in inventory of finished goods, work-in-progress and stock-in-trade 251.69 (99.57) 354.67 (,11.83)

(d) Iinployee benefits expenses 30.41 17.04 17.61 82.33 71.90

(e) Finance costs 5.78 9.36 8.00 22.97 45.46

a Depreciation and anortisation expense 4.11 4.21 5.11 16.68 20-54

(g) Other expenses 26.64 27.33 46.84 111.57 155.59

TotalExpenses 895.56 387.85 275.71 1,594.63 1,137.04

Profit / qo8s) from ordinary activities before exceptional items (1.2) 285.48 166.24 65.80 455.18 105.93

Exceptional items

Profit / qos§) before tax (3 +/- 4) 285.48 166.24 65.80 455.18 103.95

Tar expense73.31 41.75 20.15 117.33 30.75- Cunent tax

- Defro tax (0.63) 1.71 3,'2 (2.43) (1.10)

Total Tar apcnees 72.68 45.44 Z3.47 114.90 29.65

Profit / qoss) for the pedod (5 +/. 6) 212,80 122,80 42.32 340.28 74.30

Othercomprchensiveincome,netofincomctax

0.02 (0.03) (0.14) (0.30) 0.02

A, (i) Items that will be rcelas§ified (o profi( or loss

(il) Income tax relating to lteus that ion be reclassified to profit of loss8. (i) Items that win not be reclassified to profit or Loss

(ji)IncomecaxrelatingtoitemsthatwiHnotber¢c]assifiedtoprofi[orloss (0.00) 0.03 0.08 (0.01)

TctalOthercomprehensiveincome,nctofincomctax 0.02 (0.03) (0.11) (0.22) 0.01

Tctail Comprehensive income for the period (8 +/- 7) 212.82 122,77 4221 340.06 74.}1

Paid.upequitysharecapital¢acevalueofRsl0/-per§hare) 24.5086,86 24.5050.12 24.5017,27 24.50 24.50

1112 Reserve excluding Revalution Reserves as per balance sheet of previous I,193.14138.89 853-0730.33

accounting year

Eamingpersharea3PS)(of Rs.10/.each)(notamualised}Basic / Diluted EPS

PART 11

STATRENT or AUDITED AssETs Alvl) LIABnlTms As AT 5isT MARCH, 2o2o

ate.in hkhe)SrNo Particulas Asat31J)3.2020Audited dsa(31fl3.2019Audited

A ASSETS

97.51 113.788.527.321.15

12B12 Non . Current Assets

(a) Propeny, plant and equipment® Capital wcirk - in - progress 3.24

(c} Investment propeny 8.117.32

(d) Financial assets

(i) Other froancial assets

(e) Other non . currem tar assets 7.26

($ Other non - current asets 1.19

Sub total - Non - Cunent dssets 1Z4.63 130.77

CurrmtAssct§155.411,2,9.89 957.443}3-01(a) Inventories

a) Financial assets

(i) Trade receivAbles

(ii) Cash and cash equivalents 55.31 24.90

(iii) Other financial assets 0.5985.85 0.54

(c) Other tax asets (net) 836

(d) OIher cLlrrent assets 60.07

Sub total - Cunent Assets 1,537.05 1,384.52

Total - Assets 1'661.68 1,515.09

EQUITrArmLIABILmEsEQUITY

24.50 24,50(a) Equity share capital

a) other Equity i,193.14 853,07

Total-Equity 1,217.64 877.57

LueELITIEs

9,33 11.83

Non Curmt hiabiHties

(a) Dcfelfed tax liabilities O[e[)Sub total -Won- Current liabilities 9.33 11.83

Current habilities

250.30 579.42(a} Financial lfal]hides

(i) Bormwings

(u) Tnde payables 74.01 34.13

a) Otlier froancial liabhities 13.93 2.05

(c) Other current habilitles 79.86 I.24

(c) Provisions 9.05 8.85

(d) Current ten ifeilities O!et) 7.56

Sol)- total - Current Lial]ilities 434.71 625.69

Total - Ifroilities 444.04 637.52

Total - Equity and Lichffties 1,661.68 1,515.09

casH FLow sThTEMnNT FOR TEE VEAR ENDEI) 3rsT MARCH, 2o20

ate.in kThs)Partictilars Year mded

31.Mar-ZOchdited 31.Mar-19Audited

A8C cAsll FI,Ow FROM OpERAENG AcnvITIEs455.1816.68 103.9520.54Net Proft before tax and Extrndinary Items

Adju§tmentfor:Deprechtion/Amofdsation

Interest Income (0.66) a.66)Reclassificationofremeasurementofemployeebenefits (0.30) 0.02

Interes[Expenses 20.060.05 45.46

Net gch on sale of Asset (0.06)

hvesment Expenses 0.08

Sundry balance Off (0.00) 0.58

OperatingProfitbrfereWorkingCaphalChanges 491.01(33.08) 167.7154.08

Adi.ustments for Working Capital ChangesIncrease@ecrease in Assets

Changes in Inventories 802.03 (134.91)

Increase®ecrease Trade Receival)le (906.88) (333.01)

Increaseroecrease in other financial and non-financial asses 0.00 (0.07)Increaseoeerease Trade payables 59.88 @7.83)

Increaseroecrease in other froancial and nan.finandal Habilities 11.88 2.05

hcreaseroecrease in Liabilities 78.62 0.35

Changes in Provisicin 0.20 a.i71Cach Generated from operations 483.66 (289.00)

Diet taxes paid / (refund) (101.40) (85.69

Net Cash from operating Activities 382.26 (374.68)

cAsll plow FROM INVEsnNG AorTvlTIEs0.24)(0.04) (0.99)purchase of Fixed Assets indnding Capital Work in Progress

Sales of Fixed Assets 0.15

Invesrment Expenses (0.Oey

Interest Received 0.60 2.69

Net Cash Used in Investing Activity (2.68) 1.77

GASH ELOw mom FINANCING Ac"TiBs(329.11) 351.36Net a)ecrcase)/ Increase in Short Ten Borrowings

Interest Paid (20.06) (45.46)

NetCashU§edinFinancingActiwlty (549.17) 305.90

NET CHANGES IN CASH a CASH EQUIVALENTS (A+B + C) 30.41 (67.02)

OPENING BALANCE or CASH a CASH EQtrvALENrs 24.90 91'91cLosING BAIANCE or CASH & GASH EQulvALENTs 55.31 24.90

TRIOcHEM pRODuc'rs I.iMITED

MANtiFACTURERs oF E'rHlcAL pHARMACEUTicAL pRODucrs

R|gistered Office: 4th Floor, Samban Chambers, Sir. P. M. Road, Fort, MumbaL Maharashtra. PIN: 400001.Tclcphonc: 00 91 f22) `1082 810() Fin: I)0 91 (221 il)8J i; 181 i?-mall: info6 amphra\..com

\Tcbeitc: u`rv triochel">ru{lucis.com Corpurfte ltli`niii\ \.umber: L2 i2`j9}un 1972PLC0155;I.i

a H E fur:

2)3)4)5)6)7) The Audited financial results have been prepaed in accordance with Indian Accounting Standards ans AS), the provisions of the Ccimpanics Act,2013 (theAct), as applical]le and guidehaes issued by the Secutlties and Exchange Board Of India (SEED.

The Company has adopted lnd AS 116, effect anmlal repctrdng period bnglnning Apnd 1, 2019. The effect on adoption of lnd AS 116 on the financial resultsis insigivfirmt.

The Company o|]erates in single segment culy, i.e. chemical and pharmaceuticals, the disclosure requirement of Indian Accounting Standard QND AS-log)"Segment Reporting" is not applicable.

The figure for q`ianer ended 31st March, 2020 and 31st March 2019 are the balaming figures between audited figures of the fun financial year and thereviewed year-[ordare figures up to the third quarter of the relevali[ financial year.

The company has assessed the possible effcca; that may result from the COVID.19 pandemic on the carqung amounts Of recelvables and other assets /

liabilities. Based on the ourrem indicators of econoulc conditions, the ccimpany expeas ro recover the carrying amouut of all its assets. The actual inpactof the COVID-19 pandemic may be different from that estimated as at the date of approval of these financial results and the company will continue to closelymonitor any material changes (a the economic conditions in the future.

The Corresponding flgrres of the previous quarter / year have been regrouped, recasted and redassified to make them comparalle wherever necessary... ----` ` ` FOR TRIOcrmM PRODucTs I,IMITED

::tee:h::#,:e, 2o2o 3:i,=:';3~1 RAMU S'TARAM DE°RA !!gt|!:'2iyo;Ei#A:#2;yE°RA D[¥orgcoR:gE2:3E£

TRIOCREM PRODUCTS LIMITED

Registered Office: Samhava Chambers, 4th Floor, Sir P. M. Road, Fort, Mumbai . 400 001

website: www.triochemproduets.com

GIN: L24249MH1972PLC015544

qu. in lakbs) Except EPSEmac[ of Audited Financial Results for the Quattef and Year Ended 31st March, 2020Sr Pardcuhars For the For the For the For the For theNo Quarter Quarter Quarter Year Ended Year Ended

Ended on Ended on Ended on On On

51-Mar-20 31-Dec-19 31.Mar-19 31-Mar-20 31-Mar-19

Audited Unaudited Umudited Audited Audited

1 Total Income from operations 1,181-04 554.09 341,50 2,049.81 1,240.99

2 Net Profit / qoss) for the period @efore Tax, 285.48 166.24 65.80 455.18 103.95

Exceptionaland/orExtraordinaryitems)

3 Net Profit / qoss) for the period before tax (after 285.48 166.24 65.80 455.18 103.95

Exceptiomland/orExtraordinaryitens)

4 Net Profit / puss) for the period after tax (after 212.80 122.80 42.32 340.28 74.30Exceptiona`land/orEmordinaryitems)

5 Total Comprehensive Income for the period 0.02 (0.03) (0.11) (0.22) 0.01

Comprising Profit / qoss) for the period (ater tax) andother Comprehensive Income (after tar) I

6 Equity shoe capital Giace value Rs.10/-per share) 24.50 24.50 24.50 24.50 24.50

7 Reserve erduding Revalution Reserves as per balance 1,193.14 853.07

sheetofpreviousaccountingyear

8 Earnings per share q3PS) (of Rs.10/- each) (for

86.86 50.12 17.27 138.89 30.33

continuing and discontinued operations)

a) Basic (not anualized)b) Diluted (not annuaHzed) 86.86 50.12 17.27 138.89 30.35

Notes:

1) The above audited financial results of the Company for the quarter and year ended March 31,2020 have been I.evicwedby the Audit committee of the Board and approved by the Board of Directors at its meeting held on 27.06.2020

2) The Audited financial results have been prepared in accordance with Indian Accounting Standards qns AS) , the

provisions of the Companies Act,2013 (the Act) , as appricable and guideines issued by the Securities and Exc:hangeBoard of lndia (SEEP.

3) The Company has adopted lnd AS 116, effee[ arinual reporting period bcgiming Aprfu 1, 2019. The effect on adeptionoflnd AS 116 on the financial results is insignificant.

4) The Company operates in single segment only, i.e. chendcal and pharmaceutcals, the disclosure requirement of IndianAccounting Standard qul) AS-108) "Segment Reporhag" is not applicable.

5) The figue for quarter ended 31st March, 2020 and 31st March 2019 are the balancing figures between audited figures othe full financial year and the reviewed year-to.date figures up [o the third quarter of the relevant financial year.

TmH®CHEM pR®E)UCTS mMITEDMANUEACTURERs OF ETHlcAL pHARMACEuncAL pRODuc'rs

Rqgisrered Office: 4th Floor, Samhara Chambers, Sir. P. M. Road, Fort Mumba} Maharashtra,

PIN: ioooo1. Telcohone.: 00 `)I (22) j082 SIOO +`ai: 00 91 (22`) ii082 8181

E-"ill; info(Ctcam plifav.com \X'cbslle: \\1`i\..Ifiocllempro(lllcts.i`om

CorDorale [deniin' \-umber: I,j!.ij!-i9.\1H ]9T2PLC0155+I

a fr3 E ftei

6) The company has assessed the possible effects that may result from the COVID-19 pandemic on the carrying amounts areceiwhles and other assets / liabhities. Based on the current indieators of economic conditions, the company expects torecover the carrying amount Of all its assets. The actual inpact of the COVID-19 pandemic may be different from thatestimated as at the date of approval of these financial results and the company will continue [o closely monitor anymaterial changes to the economic conditions in the future.

D The Corresponding figures of the previous quarter / year have been regrouped, recasted and reclassified to make themcomparable wherever necessary.

8) The above is an extract of the detailed format Of financial results filed with the Stock Exchange under Regulation 33 Ofthe SEBI qisting and Other Disclosure Requirements) Regulation, 2015. The full format of consoridated froancial resultsare available on the Stock Exchange website, wwwbseindia.com and on the Company's website~.triochemproducts.com

~ . . . . . FOR TRIoclmM PRODucTS LIMITED

::,:d¥::hb,arune, 2.2. ,,,iij,,:=i];RAs,TARAM Egt#:yo;:g:#2;y D¥£E:3::E2:,E:` ` -``. --...

\\

Page 2 Of 2